Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Licenses BioHelix's Amplification Technology

NEW YORK (GenomeWeb News) – Qiagen said today it has licensed technology from BioHelix that is used to detect and analyze target molecules.
Under the non-exclusive, worldwide agreement, Qiagen will license and supply BioHelix’s Helicase Dependent Amplification technology, which is used to detect and analyze biological target molecules such as DNA and RNA.
Unlike PCR amplification, HDA functions at a constant temperature, which Qiagen said eliminates the need for some expensive hardware. It also is compatible with qualitative and quantitative fluorescent detection technologies and with instrumentation that is designed for use with real-time PCR.
In addition, Qiagen said the HDA technology is compatible with its Hybrid Capture detection platforms, which includes an instrument used in the company’s tests for human papillomavirus, chlamydia trachomatis, and neisseria gonorrhoeae.
The HAD technology also could be used in development of simple and portable DNA point-of-care diagnostic devices, Qiagen said.
“The ability to amplify DNA or RNA using an isothermal amplification system opens up a wide field of new assays in many areas, in particular in human molecular diagnostics and applied testing,” Jim Godsey, senior VP of R&D in North America for Qiagen, said in a statement.
Financial terms of the agreement were not released.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.